{"id":"https://openalex.org/W4415814977","doi":"https://doi.org/10.3390/cancers17213555","title":"Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives","display_name":"Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives","publication_year":2025,"publication_date":"2025-11-02","ids":{"openalex":"https://openalex.org/W4415814977","doi":"https://doi.org/10.3390/cancers17213555","pmid":"https://pubmed.ncbi.nlm.nih.gov/41228348","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12609815"},"language":"en","primary_location":{"id":"doi:10.3390/cancers17213555","doi":"https://doi.org/10.3390/cancers17213555","is_oa":true,"landing_page_url":"https://doi.org/10.3390/cancers17213555","pdf_url":"https://www.mdpi.com/2072-6694/17/21/3555/pdf?version=1762081703","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2072-6694/17/21/3555/pdf?version=1762081703","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023135289","display_name":"Pierre\u2010Etienne Gabriel","orcid":"https://orcid.org/0009-0000-5263-1398","observed_orcids":["https://orcid.org/0009-0000-5263-1398"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre-Etienne Gabriel","raw_affiliation_strings":["Department of Urology, Bichat Claude-Bernard Hospital, Assistance Publique-H\u00f4pitaux de Paris Nord, University Paris Cit\u00e9, 75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Bichat Claude-Bernard Hospital, Assistance Publique-H\u00f4pitaux de Paris Nord, University Paris Cit\u00e9, 75018 Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083361833","display_name":"Amir Horowitz","orcid":"https://orcid.org/0000-0003-3100-2810","observed_orcids":["https://orcid.org/0000-0003-3100-2810","https://orcid.org/0000-0003-4602-1440"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir Horowitz","raw_affiliation_strings":["Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061349789","display_name":"F\u00e9lix Guerrero\u2010Ramos","orcid":"https://orcid.org/0000-0002-0767-3465","observed_orcids":["https://orcid.org/0000-0002-0767-3465"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210137474","display_name":"Hospital Universitario HM Sanchinarro","ror":"https://ror.org/04jep6391","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122338","https://openalex.org/I4210137474"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Felix Guerrero-Ramos","raw_affiliation_strings":["Department of Urology, 12 de Octubre University Hospital, Av C\u00f3rdoba s/n, 28041 Madrid, Spain","Department of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0002-0767-3465","affiliations":[{"raw_affiliation_string":"Department of Urology, 12 de Octubre University Hospital, Av C\u00f3rdoba s/n, 28041 Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]},{"raw_affiliation_string":"Department of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain","institution_ids":["https://openalex.org/I4210137474"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011013432","display_name":"Francesco Soria","orcid":"https://orcid.org/0000-0001-8443-8453","observed_orcids":["https://orcid.org/0000-0001-8443-8453"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Soria","raw_affiliation_strings":["Division of Urology, AOU Citta della Salute e della Scienza di Torino, Torino School of Medicine, 10126 Torino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urology, AOU Citta della Salute e della Scienza di Torino, Torino School of Medicine, 10126 Torino, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083351538","display_name":"Marco Moschini","orcid":"https://orcid.org/0000-0002-3084-2458","observed_orcids":["https://orcid.org/0000-0002-3084-2458"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Moschini","raw_affiliation_strings":["Department of Urology, San Raffaele Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20132 Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, San Raffaele Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20132 Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024662180","display_name":"David D\u2019Andrea","orcid":"https://orcid.org/0000-0003-1625-1077","observed_orcids":["https://orcid.org/0000-0003-1625-1077"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"David D\u2019Andrea","raw_affiliation_strings":["Department of Urology, Medical University of Vienna, 1090 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Medical University of Vienna, 1090 Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038866794","display_name":"Benjamin Prad\u00e8re","orcid":"https://orcid.org/0000-0002-7768-8558","observed_orcids":["https://orcid.org/0000-0002-7768-8558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Prad\u00e8re","raw_affiliation_strings":["Department of Urology, La Croix Du Sud Hospital, 31130 Quint Fonsegrives, France"],"raw_orcid":"https://orcid.org/0000-0002-7768-8558","affiliations":[{"raw_affiliation_string":"Department of Urology, La Croix Du Sud Hospital, 31130 Quint Fonsegrives, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010082766","display_name":"John P. Sfakianos","orcid":"https://orcid.org/0000-0002-3101-0266","observed_orcids":["https://orcid.org/0000-0002-3101-0266"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P. Sfakianos","raw_affiliation_strings":["Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020529503","display_name":"Evanguelos N. Xylinas","orcid":"https://orcid.org/0000-0002-9440-4895","observed_orcids":["https://orcid.org/0000-0002-9440-4895"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Evanguelos Xylinas","raw_affiliation_strings":["Department of Urology, Bichat Claude-Bernard Hospital, Assistance Publique-H\u00f4pitaux de Paris Nord, University Paris Cit\u00e9, 75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Bichat Claude-Bernard Hospital, Assistance Publique-H\u00f4pitaux de Paris Nord, University Paris Cit\u00e9, 75018 Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5020529503"],"corresponding_institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210145170"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.484,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.52094241,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"17","issue":"21","first_page":"3555","last_page":"3555"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/systemic-immunotherapy","display_name":"systemic immunotherapy","score":0.9509999752044678},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8700000047683716},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9559999704360962},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":1.0},{"id":"https://openalex.org/keywords/bcg-unresponsive-disease","display_name":"BCG-unresponsive disease","score":0.7760000228881836},{"id":"https://openalex.org/keywords/pd-1-pd-l1-axis","display_name":"PD-1/PD-L1 axis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9750000238418579},{"id":"https://openalex.org/keywords/patient-selection-for-immunotherapy","display_name":"immunotherapy selection","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.838100016117096},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.8054999709129333},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.515500009059906},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4406999945640564},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.4187000095844269},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41589999198913574},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.39649999141693115},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.3799000084400177},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.359499990940094},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.35519999265670776},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34529998898506165},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.3402999937534332},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3154999911785126},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.3098999857902527},{"id":"https://openalex.org/C46622094","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic window","level":2,"score":0.29809999465942383},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.2637999951839447},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.2621000111103058}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3390/cancers17213555","doi":"https://doi.org/10.3390/cancers17213555","is_oa":true,"landing_page_url":"https://doi.org/10.3390/cancers17213555","pdf_url":"https://www.mdpi.com/2072-6694/17/21/3555/pdf?version=1762081703","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11414627","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12609815","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41228348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41228348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3390/cancers17213555","doi":"https://doi.org/10.3390/cancers17213555","is_oa":true,"landing_page_url":"https://doi.org/10.3390/cancers17213555","pdf_url":"https://www.mdpi.com/2072-6694/17/21/3555/pdf?version=1762081703","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415814977.pdf","grobid_xml":"https://content.openalex.org/works/W4415814977.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1863833365","https://openalex.org/W2002045993","https://openalex.org/W2030874794","https://openalex.org/W2116195839","https://openalex.org/W2116299167","https://openalex.org/W2152206210","https://openalex.org/W2473162054","https://openalex.org/W2588916311","https://openalex.org/W2763670669","https://openalex.org/W2774712455","https://openalex.org/W2802590415","https://openalex.org/W2906033374","https://openalex.org/W2909679049","https://openalex.org/W2914335731","https://openalex.org/W2983476233","https://openalex.org/W2988620928","https://openalex.org/W3013725287","https://openalex.org/W3026369794","https://openalex.org/W3035054336","https://openalex.org/W3043639697","https://openalex.org/W3163995648","https://openalex.org/W3164781831","https://openalex.org/W3172091771","https://openalex.org/W3210650932","https://openalex.org/W4206028884","https://openalex.org/W4224283600","https://openalex.org/W4295592571","https://openalex.org/W4318387439","https://openalex.org/W4320915119","https://openalex.org/W4366339435","https://openalex.org/W4385331153","https://openalex.org/W4385857188","https://openalex.org/W4386019206","https://openalex.org/W4387859553","https://openalex.org/W4388945551","https://openalex.org/W4390063180","https://openalex.org/W4391341058","https://openalex.org/W4392498919","https://openalex.org/W4396827653","https://openalex.org/W4399391636","https://openalex.org/W4401664244","https://openalex.org/W4402548582","https://openalex.org/W4406245972","https://openalex.org/W4410916531","https://openalex.org/W4414083702","https://openalex.org/W4415281009","https://openalex.org/W4415297453"],"related_works":["https://openalex.org/W4412197875","https://openalex.org/W4414169173","https://openalex.org/W4200456630","https://openalex.org/W4205103362","https://openalex.org/W7128928011","https://openalex.org/W4408939672","https://openalex.org/W4412891722","https://openalex.org/W3092676705","https://openalex.org/W3151253846","https://openalex.org/W3175116112"],"abstract_inverted_index":{"BACKGROUND/OBJECTIVES:":[0],"Systemic":[1],"immunotherapy,":[2],"previously":[3],"used":[4],"mainly":[5],"for":[6,175],"advanced":[7],"urothelial":[8],"carcinoma,":[9],"now":[10],"plays":[11],"an":[12],"important":[13],"role":[14],"in":[15,55,82],"the":[16,41,137,141,176,236],"treatment":[17],"of":[18,59,104,201,238],"non-muscle":[19],"invasive":[20],"bladder":[21],"cancer":[22],"(NMIBC),":[23],"either":[24],"alone":[25],"or":[26],"combined":[27,158],"with":[28,106,159,171,225],"intravesical":[29],"BCG":[30,156,239],"instillations.":[31],"METHODS:":[32],"We":[33],"conducted":[34],"a":[35,107,123,131,210,226,244],"collaborative,":[36],"comprehensive":[37],"review":[38],"to":[39,84,97,101,114,189,206,221],"summarize":[40],"key":[42,182],"evidence":[43],"and":[44,65,78,140,168,178,204,231,241],"future":[45,212],"perspectives":[46],"on":[47],"therapeutic":[48],"intensification":[49,216],"strategies":[50],"involving":[51],"immune":[52],"checkpoint":[53],"inhibitors":[54],"NMIBC.":[56],"A":[57],"total":[58],"51":[60],"references":[61],"published":[62],"between":[63],"2000":[64],"2025":[66],"were":[67],"included.":[68],"RESULTS:":[69],"Four":[70],"phase":[71,124,151],"II":[72,125],"studies":[73,153],"evaluated":[74],"pembrolizumab,":[75],"atezolizumab,":[76],"durvalumab,":[77],"cetrelimab":[79],"as":[80],"monotherapy":[81],"28":[83],"132":[85],"BCG-unresponsive":[86,223],"NMIBC":[87],"patients.":[88],"They":[89],"reported":[90,174],"complete":[91],"response":[92,109,205],"rates":[93],"ranging":[94,111],"from":[95,112,191],"12%":[96],"43%":[98],"after":[99],"3":[100],"12":[102,117],"months":[103],"treatment,":[105],"durable":[108],"rate":[110],"49%":[113],"57.4%":[115],"at":[116],"months.":[118],"To":[119],"improve":[120],"these":[121],"results,":[122],"trial":[126],"launched":[127],"this":[128,192],"year":[129],"tests":[130],"new":[132,227],"systemic":[133,160,218],"combination":[134,193,237],"targeting":[135],"both":[136,222],"PD-1/PD-L1":[138],"axis":[139],"emerging":[142],"HLA-E/NKG2A":[143],"pathway.":[144],"Regarding":[145],"BCG-na\u00efve":[146,232],"high-risk":[147],"(HR)":[148],"NMIBC,":[149,224,234],"four":[150],"III":[152],"are":[154],"evaluating":[155],"instillations":[157,240],"immunotherapy:":[161],"sasanlimab":[162],"(CREST),":[163],"durvalumab":[164],"(POTOMAC),":[165],"atezolizumab":[166],"(ALBAN),":[167],"pembrolizumab":[169],"(KEYNOTE-676),":[170],"significant":[172],"results":[173],"CREST":[177],"POTOMAC":[179],"trials.":[180],"The":[181],"challenge":[183],"remains":[184],"selecting":[185],"patients":[186],"most":[187],"likely":[188],"benefit":[190],"therapy":[194],"while":[195],"avoiding":[196],"overtreatment.":[197],"Identifying":[198],"predictive":[199],"biomarkers":[200],"tumor":[202],"aggressiveness":[203],"immunotherapy":[207,219,242],"also":[208],"represents":[209,243],"major":[211,245],"challenge.":[213],"CONCLUSIONS:":[214],"Therapeutic":[215],"using":[217],"applies":[220],"target":[228],"pathway":[229],"(HLA-E/NKG2A),":[230],"HR":[233],"where":[235],"breakthrough.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-03T00:00:00"}